CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $497,000 | -85.9% | 236,017 | -80.6% | 0.00% | – |
| Q1 2021 | $3,523,000 | +41.1% | 1,218,977 | +4.5% | 0.00% | – |
| Q4 2020 | $2,496,000 | -63.8% | 1,166,782 | +4.6% | 0.00% | – |
| Q3 2020 | $6,904,000 | -3.1% | 1,115,370 | +0.7% | 0.00% | – |
| Q2 2020 | $7,126,000 | +623.5% | 1,108,118 | +367.1% | 0.00% | – |
| Q1 2020 | $985,000 | -25.5% | 237,235 | +6.0% | 0.00% | – |
| Q4 2019 | $1,323,000 | +44.3% | 223,844 | +31.8% | 0.00% | – |
| Q3 2019 | $917,000 | -34.2% | 169,786 | -1.7% | 0.00% | – |
| Q2 2019 | $1,393,000 | +192.6% | 172,679 | +186.8% | 0.00% | – |
| Q1 2019 | $476,000 | – | 60,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |